Edmond de Rothschild Holding’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Edmond de Rothschild Holding’s Portfolio BXRX Stock Details BXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-71	Closed	-$226	–	835
2022 Q4	$226	Hold	71	–	–	﹤0.01%	783
2022 Q3	$1K	Buy	+71	New	+$1.65K	﹤0.01%	824
2022 Q2	–	Sell	-71	Closed	-$5K	–	894
2022 Q1	$5K	Hold	71	–	–	﹤0.01%	800
2021 Q4	$22K	Hold	71	–	–	﹤0.01%	769
2021 Q3	$56K	Hold	71	–	–	﹤0.01%	684
2021 Q2	$76K	Hold	71	–	–	﹤0.01%	641
2021 Q1	$129K	Buy	+71	New	+$142K	﹤0.01%	534

Other funds holding BXRX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Edmond de Rothschild Holding's BXRX Position: Q1 2023 in Review

Edmond de Rothschild Holding sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q1 2023, closing a stake of 71 shares — an estimated $226 sold.

Edmond de Rothschild Holding first reported a position in BXRX in Q1 2021 and held it in 7 quarters. The position peaked at $129K in Q1 2021. 12 funds tracked by Wall St. Rank hold BXRX as of Q1 2023.

Edmond de Rothschild Holding reported no remaining Baudax Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Edmond de Rothschild Holding sold 71 Baudax Bio, Inc. Common Stock shares in Q1 2023, an estimated $226.
Edmond de Rothschild Holding first reported a position in Baudax Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Edmond de Rothschild Holding's Baudax Bio, Inc. Common Stock position peaked at $129K in Q1 2021.
12 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q1 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2023, filed 11 May 2023.